MACQUARIE GROUP LTD 13D/13G Filings for Adamas Pharmaceuticals, Inc. (ADMS)

MACQUARIE GROUP LTD 13D and 13G filings for Adamas Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
08:23 am
Sale
2020-12-3113GAdamas Pharmaceuticals, Inc.
ADMS
MACQUARIE GROUP LTD0
0.000%
-2,167,416decrease
(Position Closed)
Filing